Shuttle Pharmaceuticals Holdings (SHPH) Amortizatization of Intangibles (2021 - 2026)

Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Amortizatization of Intangibles of $12122.0 in Q1 2026, down 12.92% quarter-over-quarter from $13921.0 in Q4 2025, and up 85.49% on a YoY basis from $6535.0 in Q1 2025.

Shuttle Pharmaceuticals Holdings (SHPH) Amortizatization of Intangibles (2021 - 2026) Analysis & Trends

Shuttle Pharmaceuticals Holdings' Amortizatization of Intangibles history runs 6 years deep, the most recent figure standing at $12122.0 for Q1 2026.

  • In Q1 2026, Amortizatization of Intangibles rose 85.49% year-over-year to $12122.0; the TTM figure through Mar 2026 stood at $659978.0 (up 3.05% YoY), while the FY2025 annual figure was $62030.0, down 94.25% from the prior year.
  • Amortizatization of Intangibles was $12122.0 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $13921.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $606974.0 in Q3 2022 to a low of -$508121.0 in Q4 2022.
  • Historically, Amortizatization of Intangibles has averaged $265399.4 across 5 years, with a median of $316967.5 in 2024.
  • The sharpest annual moves came in 2022 and 2023: Amortizatization of Intangibles sank 3676.3% in 2022, then soared 337.84% in 2023.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$508121.0 in 2022, then jumped by 192.17% to $468325.0 in 2023, then plunged by 47.17% to $247430.0 in 2024, then tumbled by 94.37% to $13921.0 in 2025, then declined by 12.92% to $12122.0 in 2026.
  • The last three Amortizatization of Intangibles figures came in at $12122.0 (Q1 2026), $13921.0 (Q4 2025), and $247430.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.30 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 242,000.00
10 Shuttle Pharmaceuticals Holdings 2.43 Mn 1.36 Mn - 12,122.00

Historic Data

Download Data
DateValue
Mar 31, 2026 12,122.00
Mar 31, 2026 12,122.00
Dec 31, 2025 13,921.00
Dec 31, 2025 13,921.00
Sep 30, 2025 247,430.00
Sep 30, 2025 247,430.00
Jun 30, 2025 386,505.00
Jun 30, 2025 386,505.00
Mar 31, 2025 6,535.00
Mar 31, 2025 6,535.00
Sep 30, 2024 247,430.00
Sep 30, 2024 247,430.00
Jun 30, 2024 386,505.00
Jun 30, 2024 386,505.00
Mar 31, 2024 445,509.00
Mar 31, 2024 445,509.00
Dec 31, 2023 468,325.00
Dec 31, 2023 468,325.00
Sep 30, 2023 538,302.00
Sep 30, 2023 538,302.00